Pharmacokinetic/pharmacodynamic modeling in drug development

Annual Review of Pharmacology and Toxicology

Volumn 40, Issue , 2000, Pages 67-95

  Sheiner, L B ^a   Steimer, J L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Confirming; Empirical models; Learning; Mechanistic models; Predictive models; Statistical modeling

Indexed keywords

DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG RESEARCH; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; STATISTICAL MODEL;

ANIMALS; DRUG DESIGN; HUMANS; MODELS, STATISTICAL; PHARMACOKINETICS; PHARMACOLOGY; PROBABILITY;

EID: 0034119297     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.40.1.67     Document Type: Review

References (16)

1. Holford N, Sheiner L. 1981. Understanding the dose-effect relationship: clinical applications of pharmacokinetic/pharmacodynamic models. Clin. Pharmacokinet. 6:429-53
2. Holford N, Sheiner L. 1981. Pharmacokinetic and pharmacodynamic modelling in vivo. CRC Crit. Rev. Bioeng. 5:273
3. Derendorf H, Meibohm B. 1999. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm. Res. 16:176-85
4. Senn S. 1997. Statistical Issues in Drug Development. Statistics in Practice. New York: Wiley
5. Campbell D. 1990. The use of kineticdynamic interactions in the evaluation of drugs. Psychopharmacology 100:433-50
6. Lave T, Coassolo P, Reigner B. 1999. Prediction of hepatic metabolism clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations. Clin. Pharmacokinet. 36:211-31
7. Mandema J. 1991. EEG effect measures and relationships between pharmacokinetics and pharmacodynamics of psychotropic drugs. PhD thesis. Leiden Univ., Leiden, The Netherlands. 318 pp.
8. Mathot R. 1995. Preclinical pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of adenosine receptor ligands. PhD thesis. Leiden Univ., Leiden, The Netherlands. 306 pp.
9. Cox E. 1997. Preclinical pharmacokinetic-phamacodynamic relationships of synthetic opioids. PhD thesis. Leiden Univ., Leiden, The Netherlands. 207 pp.
10. Della Paschoa O. 1998. Preclinical pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect. PhD thesis. Leiden Univ., Leiden, The Netherlands. 237 pp.
11. Blower S, Porco T, Darby G. 1998. Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat. Med. 4:673-78
12. Sheiner L. 1997. Learning versus confirming in clinical drug development. Clin. Pharmacol. Ther. 61:275-91
13. Food Drug Admin. 1997. Food Drug Mod. Act 1997. Subsect. 115: Food Drug Cosmet. Act, Sect. 505D. Washington, DC: US Gov. Print. Off.
14. 13a. Holford NHG, Kimko HC, Monteleone JPR, Peck CC. 2000. Simulation of Clinical Trials. Annu. Rev. Pharm. Tox. 40:209-34.
15. Davidian M. Giltinan D. 1995. Nonlinear Models for Repeated Measurement Data. London: Chapman & Hall
16. Gelman A, Carlin J, Stem H, Rubin D. 1995. Bayesian Data Analysis. London: Chapman & Hall